Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma.

Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma. — المؤلف: Gu, Chunyan — BMC cancer 20190312

المؤلف
Gu, Chunyan
النشر
BMC cancer 20190312
الوصف
1152 p.
الموضوعات
Animals؛ Antineoplastic Agents؛ Bortezomib؛ Cell Line, Tumor؛ Cell Proliferation؛ Cell Survival؛ Doxorubicin؛ Drug Resistance